ABOUT MEDTRACE PHARMA

We are a development stage company aiming to innovate PET diagnostic imaging.

Our team

Martin Stenfeldt

CEO

Rune Wiik Kristensen

Chief Operational Officer

Dorte Thulstrup

VP, Regulatory Affairs & Quality assurance

Hans Harms, Ph.D.

VP, aQuant Development

Karina Kück

coordinator, Regulatory affairs & quality assurance

Kasper Lykkegaard Therkelsen

Design & usability lead

Teresa Lorrio Gonzales

SOFTWARE DEVELOPer

Mark Gockenbach

Coordinator, SoftWare deployment

Yumi Murakami

Country manager japan

Lars Poulsen Tolbod, Ph.D.

New indications specialist

Peter Larsen, Ph.D.

Advisor, hardware development

Jens Soerensen, M.D., Professor

clinical advisor

Group 7Created with Sketch.

Mark Lubberink, Professor

scientific advisor

Helle Rasmussen

Bookkeeper

Rebekka Stenfeldt

STUDENT ASSISTANT,
BUSINESS SUPPORT

Our board of directors

Ulrik Spork

Chairman

Mads Rasmussen

Vice-chairman

Group 7Created with Sketch.
Michael Frank

Director

Bernt Skov Jensen

Director

Jens Soerensen, M.D., Professor

Director & CMO

Group 6Created with Sketch.

”The availability of a reliable approved system for bed-side production of 15O-water could change 15O-water PET from an exotic research tool to a clinical workhorse”

Martin Stenfeldt, CEO, MedTrace Pharma